Latanoprost Stada

Latanoprost, the active ingredient in Latanoprost Stada, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It lowers intra‑ocular pressure in patients with primary open‑angle glaucoma or ocular hypertension.

GNH USA supplies Latanoprost Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost is a prostaglandin analog used to manage conditions that involve elevated intra‑ocular pressure. - Primary open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression. - Ocular hypertension: lowers pressure to prevent development of glaucoma. - Secondary open‑angle glaucoma: helps control pressure when caused by other ocular conditions.

Latanoprost may cause ocular and peri‑ocular reactions.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Increased eyelash growth: longer, thicker lashes. - Iris darkening: gradual hyperpigmentation of the iris. - Eye irritation: burning or stinging sensation. - Blurred vision: transient visual disturbance. - Foreign body sensation: feeling of grit in the eye.

Serious or Rare Side Effects: - Severe eye inflammation: uveitis or iritis. - Allergic reaction: swelling, rash, or severe itching. - Vision loss: sudden decrease in visual acuity. - Paradoxical IOP increase: unexpected rise in pressure. - Ocular infection: risk of bacterial or fungal infection. - Corneal edema: swelling of the cornea.

Before using Latanoprost, consider the following safety measures. - Monitor intra‑ocular pressure: regular eye examinations are required. - Avoid use in active ocular infection: infection may worsen. - Caution with a history of uveitis: may exacerbate inflammation. - Do not wear contact lenses during treatment: lenses can trap the solution. - Pregnancy and lactation: safety not established, use only if clearly needed. - Store at ambient temperature: keep in original container, protect from light and moisture.

Latanoprost may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Other prostaglandin analog eye drops: additive pressure‑lowering effect may cause excessive reduction. - Topical non‑steroidal anti‑inflammatory drugs: may diminish Latanoprost efficacy.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: combined use can lead to overly low intra‑ocular pressure. - Systemic carbonic anhydrase inhibitors: additive IOP‑lowering effect. - Anticholinergic eye drops: may affect pupil size and ocular dynamics.